The expanding arsenal of targeted and immuno-oncology drugs has unalterably changed the landscape of systemic cancer treatment, but chemotherapy will remain critical for years if not decades to come.
Kevin Lord, PhD, MHS
Advertisement
Articles by Kevin Lord, PhD, MHS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Hybrid, Outpatient, Network-Based: Bispecific Programs Take Shape Differently
2
Chemo-Free Options Abound for Transplant-Ineligible MCL, Kumar Explains
3
Study Finds Flaw in Method for Key Oncology Value-Based Care Model
4
Defunding Co-Payment Assistance Disrupted nAMD Care
5